Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development

Molecular and Cellular Biology

Volumn 29, Issue 14, 2009, Pages 3894-3904

  Fukuyama, Tomofusa ^a   Kasper, Lawryn H ^a   Boussouar, Fayçal ^a   Jeevan, Trushar ^a   Van Deursen, Jan ^b   Brindle, Paul K ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BETA ACTIN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; EOMESODERMIN; GAMMA INTERFERON; HERMES ANTIGEN; HISTONE; HISTONE ACETYLTRANSFERASE; INTERLEUKIN 2 RECEPTOR BETA; LYSINE; PROTEIN ITK; PROTEIN P300; PROTEIN RLK; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; BETA CHAIN; CBP GENE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CHROMATIN; CONTROLLED STUDY; EFFECTOR CELL; EGR2 GENE; EGR3 GENE; GENE; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSCRIPTION; IL2 GENE; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; MOUSE; MUTANT; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS;

ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CREB-BINDING PROTEIN; DNA PRIMERS; FEMALE; GENE EXPRESSION; HISTONE ACETYLTRANSFERASES; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS;

MUS;

EID: 67650095155     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01598-08     Document Type: Article

References (47)

1. Allis, C. D., S. L. Berger, J. Cote, S. Dent, T. Jenuwien, T. Kouzarides, L. Pillus, D. Reinberg, Y. Shi, R. Shiekhattar, A. Shilatifard, J. Workman, and Y. Zhang. 2007. New nomenclature for chromatin-modifying enzymes. Cell 131:633-636.
2. + T cells. Immunity 25:79-91.
3. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336.
4. + T-cell development. Nat. Rev. Immunol. 7:479-485.
5. + T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 25:93-104.
6. Brunner, C., A. Sindrilaru, I. Girkontaite, K. D. Fischer, C. Sunderkotter, and T. Wirth. 2007. BOB. 1/OBF. 1 controls the balance of TH1 and TH2 immune responses. EMBO J. 26:3191-3202.
7. Chi, T. H., M. Wan, P. P. Lee, K. Akashi, D. Metzger, P. Chambon, C. B. Wilson, and G. R. Crabtree 2003. Sequential roles of Brg, the ATPase subunit of BAF chromatin remodeling complexes, in thymocyte development. Immunity 19:169-182.
8. + T cells. Proc. Natl. Acad. Sci. USA 103:12075-12080.
9. Gebuhr, T. C., G. I. Kovalev, S. Bultman, V. Godfrey, L. Su, and T. Magnuson 2003. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J. Exp. Med. 198:1937-1949.
10. Glimcher, L. H., M. J. Townsend, B. M. Sullivan, and G. M. Lord 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4:900-911.
11. Goodman, R. H., and S. Smolik 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
12. Hennet, T., F. K. Hagen, L. A. Tabak, and J. D. Marth 1995. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl- transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA 92:12070-12074.
13. + T cells lacking T-bet and eomesodermin. Science 321:408-411.
14. + T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236-1244.
15. Joshi, N. S., and S. M. Kaech 2008. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 180:1309-1315.
16. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-851.
17. Kang-Decker, N., C. Tong, F. Boussouar, D. J. Baker, W. Xu, A. A. Leontovich, W. R. Taylor, P. K. Brindle, and J. M. Van Deursen 2004. Loss of CBP causes T cell lymphomagenesis in synergy with p27(Kip1) insufficiency. Cancer Cell 5:177-189.
18. Kappes, D. J., X. He, and X. He 2005. CD4-CD8 lineage commitment: an inside view. Nat. Immunol. 6:761-766.
19. Kasper, L. H., F. Boussouar, P. A. Ney, C. W. Jackson, J. Rehg, J. M. van Deursen, and P. K. Brindle 2002. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature 419:738-743.
20. Kasper, L. H., and P. K. Brindle 2006. Mammalian gene expression program resiliency: the roles of multiple coactivator mechanisms in hypoxia-responsive transcription. Cell Cycle 5:142-146.
21. Kasper, L. H., T. Fukuyama, M. A. Biesen, F. Boussouar, C. Tong, A. de Pauw, P. J. Murray, J. M. van Deursen, and P. K. Brindle 2006. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell. Biol. 26:789-809.
22. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, K. Brasel, P. J. Morrissey, K. Stocking, J. C. Schuh, S. Joyce, and J. J. Peschon 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
23. Kim, J., J. Lee, N. Yadav, Q. Wu, C. Carter, S. Richard, E. Richie, and M. T. Bedford 2004. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J. Biol. Chem. 279:25339-25344.
24. Kioussis, D., and K. Georgopoulos 2007. Epigenetic flexibility underlying lineage choices in the adaptive immune system. Science 317:620-622.
25. Kuo, H. Y., C. C. Chang, J. C. Jeng, H. M. Hu, D. Y. Lin, G. G. Maul, R. P. Kwok, and H. M. Shih 2005. SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc. Natl. Acad. Sci. USA 102:16973-16978.
26. Lee, P. P., D. R. Fitzpatrick, C. Beard, H. K. Jessup, S. Lehar, K. W. Makar, M. Perez-Melgosa, M. T. Sweetser, M. S. Schlissel, S. Nguyen, S. R. Cherry, J. H. Tsai, S. M. Tucker, W. M. Weaver, A. Kelso, R. Jaenisch, and C. B. Wilson 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15:763-774.
27. Ma, H., C. Nguyen, K. S. Lee, and M. Kahn 2005. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 24:3619-3631.
28. McManus, K. J., and M. J. Hendzel 2003. Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin. Mol. Cell. Biol. 23:7611-7627.
29. Miller, A. T., and L. J. Berg 2002. Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase. J. Immunol. 168:2163-2172.
30. Oukka, M., M. N. Wein, and L. H. Glimcher 2004. Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells. J. Exp. Med. 199:15-24.
31. + T cell function by the transcription factor eomesodermin. Science 302:1041-1043.
32. Reiner, S. L. 2005. Epigenetic control in the immune response. Hum. Mol. Genet. 14(Spec. no. 1):R41-R46.
33. Rothenberg, E. V. 2007. Cell lineage regulators in B and T cell development. Nature Immunol. 8:441-444.
34. Schaeffer, E. M., J. Debnath, G. Yap, D. McVicar, X. C. Liao, D. R. Littman, A. Sher, H. E. Varmus, M. J. Lenardo, and P. L. Schwartzberg 1999. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284:638-641.
35. Spiegelman, B. M., and R. Heinrich 2004. Biological control through regulated transcriptional coactivators. Cell 119:157-167.
36. Srinivas, S., T. Watanabe, C. S. Lin, C. M. William, Y. Tanabe, T. M. Jessell, and F. Costantini 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1:4.
37. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100:15818-15823.
38. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338-342.
39. Tanaka, Y., I. Naruse, T. Hongo, M. Xu, T. Nakahata, T. Maekawa, and S. Ishii 2000. Extensive brain hemorrhage and embryonic lethality in a mouse null mutant of CREB-binding protein. Mech. Dev. 95:133-145.
40. Wang, J., R. A. Barke, and S. Roy 2007. Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J. Biol. Chem. 282:7164-7171.
41. Williams, C. J., T. Naito, P. G. Arco, J. R. Seavitt, S. M. Cashman, B. De Souza, X. Qi, P. Keables, U. H. Von Andrian, and K. Georgopoulos 2004. The chromatin remodeler Mi-2 is required for CD4 expression and T cell development. Immunity 20:719-733.
42. - thymocytes lacking the heat-stable antigen. Cell Immunol. 117:312-326.
43. Wilson, C. B., and M. Merkenschlager 2006. Chromatin structure and gene regulation in T cell development and function. Curr. Opin. Immunol. 18:143-151.
44. Xu, W., T. Fukuyama, P. A. Ney, D. Wang, J. Rehg, K. Boyd, J. M. van Deursen, and P. K. Brindle 2006. Global transcriptional coactivators CREB-binding protein and p300 are highly essential collectively but not individually in peripheral B cells. Blood 107:4407-4416.
45. Xu, W., L. H. Kasper, S. Lerach, T. Jeevan, and P. K. Brindle 2007. Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J. 26:2890-2903.
46. Yao, T. P., S. P. Oh, M. Fuchs, N. D. Zhou, L. E. Ch'ng, D. Newsome, R. T. Bronson, E. Li, D. M. Livingston, and R. Eckner 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
47. Yu, C. T., M. H. Feng, H. M. Shih, and M. Z. Lai 2002. Increased p300 expression inhibits glucocorticoid receptor-T-cell receptor antagonism but does not affect thymocyte positive selection. Mol. Cell. Biol. 22:4556-4566.